Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

This trial tests whether using your genetic profile (pharmacogenomics) to choose psychiatric medications leads to better treatment outcomes than standard prescribing for depression, anxiety, or psychotic disorders. You may be eligible if... - You have moderate-to-severe depression, anxiety (panic or generalized), or a psychotic disorder (schizophrenia or schizoaffective disorder) - You have had an inadequate response to at least one psychiatric medication in your lifetime - You are switching to (or recently switched to) sertraline or escitalopram (for mood/anxiety), or another specified medication for psychosis You may NOT be eligible if... - You do not meet the diagnostic criteria for the conditions listed above - You have not previously tried at least one psychiatric medication - You are not in the process of switching to one of the study medications Talk to your doctor to see if this trial is right for you.